- $2.29bn
- $5.18bn
- $4.25bn
Brief: Perrigo Board Of Directors Approves 1% Increase In Quarterly Dividend To $0.276 Per Share
Perrigo Company PLC expected to post earnings of 83 cents a share - Earnings Preview
Gerber, Perrigo must face lawsuit over ‘store brand’ infant formula - U.S. judge
Brief: Perrigo Company PLC Enters Into Credit Agreement, Dated April 20, 2022
Brief: Perrigo Announces Early Results Of Cash Tender Offer For Notes
Brief: Perrigo Announces Cash Tender Offer for Notes
Perrigo Company rises on higher Q3 results
Brief: Perrigo Company Sees FY Reported Net Sales Growth Of 4.0% To 6.0%
Brief: Perrigo Q3 Sales USD 1,100 Million
Perrigo Company PLC expected to post earnings of 62 cents a share - Earnings Preview
Brief: Perrigo Announces Leadership Update
Brief: Perrigo Says Letter Co Received From FDA Pertained Only To Infant Formula Manufacturing Facility In Wisconsin, Which Co Got From Nestle On Nov 1, 2022
US FDA issues warning letters to three baby formula manufacturers (updated)
Perrigo Company PLC reports results for the quarter ended in June - Earnings Summary
Brief: Perrigo Q2 Sales USD 1,200 Million
Perrigo Company PLC expected to post earnings of 51 cents a share - Earnings Preview
Column: Here’s what AbbVie doesn’t want you to know about its sham AndroGel patent case
Press Digest: New York Times business news - July 14
U.S. STOCKS ON THE MOVE-Cryoport, cybersecurity firms, China ADRs